Semaglutide, lipid-lowering drugs, and NAFLD

被引：13

作者：

Katsiki, Niki ^{[1
]}

Athyros, Vasilios G. ^{[1
]}

Karagiannis, Asterios ^{[1
]}

Mikhailidis, Dimitri P. ^{[2
]}

机构：

[1] Aristotle Univ Thessaloniki, Hippocrat Hosp, Med Sch, Propedeut Dept Internal Med 2, Thessaloniki, Greece

[2] UCL, Dept Clin Biochem, Med Sch, Royal Free Hosp Campus, London NW3 2QG, England

来源：

LANCET DIABETES & ENDOCRINOLOGY | 2017年 / 5卷 / 05期

关键词：

FATTY LIVER-DISEASE;

D O I：

10.1016/S2213-8587(17)30109-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：329 / +

页数：3

共 50 条

[1] Semaglutide, lipid-lowering drugs, and NAFLD Reply
Sorli, Christopher
LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (05): : 330 - 330
[2] Lipid-Lowering Drugs
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1506): : 133 - 140
[3] Lipid-Lowering Drugs
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1659): : 145 - +
[4] Lipid-lowering drugs
K. Pahan
Cellular and Molecular Life Sciences CMLS, 2006, 63 : 1165 - 1178
[5] LIPID-LOWERING DRUGS
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1980, 22 (16): : 65 - 66
[6] LIPID-LOWERING DRUGS
THOMPSON, GR
LANCET, 1988, 1 (8585): : 597 - 597
[7] Lipid-Lowering Drugs
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1565): : 17 - 24
[8] Lipid-lowering drugs
Andréjak, M
Caron, J
Libersa, C
Thery, C
THERAPIE, 2003, 58 (01): : 1 - 2
[9] LIPID-LOWERING DRUGS
MCLOUGHLIN, I
CLARKE, P
BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 : 275 - 276
[10] Lipid-lowering drugs
Pahan, K.
CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (10) : 1165 - 1178